검색결과 : 11건
| No. | Article |
|---|---|
| 1 |
Unnecessary hesitancy on human vaccine tests Response Shah SK, Miller FG, Darton TC, Duenas D, Emerson C, Lynch HF, Jamrozik E, Jecker NS, Kamuya D, Kapulu M, Kimmelman J, MacKay D, Memoli MJ, Murphy SC, Palacios R, Richie TL, Roestenberg M, Saxena A, Saylor K, Selgelid MJ, Vaswani V, Rid A Science, 369(6500), 151, 2020 |
| 2 |
Ethics of controlled human infection to address COVID-19 Shah SK, Miller FG, Darton TC, Duenas D, Emerson C, Lynch HF, Jamrozik E, Jecker NS, Kamuya D, Kapulu M, Kimmelman J, MacKay D, Memoli MJ, Murphy SC, Palacios R, Richie TL, Roestenberg M, Saxena A, Saylor K, Selgelid MJ, Vaswani V, Rid A Science, 368(6493), 832, 2020 |
| 3 |
Against pandemic research exceptionalism London AJ, Kimmelman J Science, 368(6490), 476, 2020 |
| 4 |
Bystander risk, social value, and ethics of human research Shah SK, Kimmelman J, Lyerly AD, Lynch HF, Miller FG, Palacios R, Pardo CA, Zorrilla C Science, 360(6385), 158, 2018 |
| 5 |
Evaluating human trials: FDA's role Response Shah SK, Kimmelman J, Lyerly AD, Lynch HF, Miller FG, Palacios R, Pardo CA, Zorrilla C Science, 360(6395), 1308, 2018 |
| 6 |
Consider drug efficacy before first-in-human trials Kimmelman J, Federico C Nature, 542(7639), 25, 2017 |
| 7 |
Global standards for stem-cell research Kimmelman J, Hyun I, Benvenisty N, Caulfield T, Heslop HE, Murry CE, Sipp D, Studer L, Sugarman J, Daley GQ Nature, 533(7603), 311, 2016 |
| 8 |
Confronting stem cell hype Caulfield T, Sipp D, Murry CE, Daley GQ, Kimmelman J Science, 352(6287), 776, 2016 |
| 9 |
Rethinking Research Ethics: The Case of Postmarketing Trials London AJ, Kimmelman J, Carlisle B Science, 336(6081), 544, 2012 |
| 10 |
Beyond Access vs. Protection in Trials of Innovative Therapies London AJ, Kimmelman J, Emborg ME Science, 328(5980), 829, 2010 |